Community Oncology Services Market Size Projected To Reach $75.96 Billion By 2034 With A Cagr Of 8.7%

The Community Oncology Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Community Oncology Services Market?
In recent years, the market size for community oncology services has seen significant growth. It is predicted to increase from $50.54 billion in 2024 to $54.44 billion in 2025 with a compound annual growth rate (CAGR) of 7.7%. Factors such as heightened healthcare spending, a rapidly aging population, and reforms within health insurance are considered to be the main contributors to the historical growth.

The market size of community oncology services is predicted to experience robust expansion in the forthcoming years, climbing to a value of $75.96 billion in 2029 at a CAGR of 8.7%. The anticipated growth within this period can be linked to the rising incidence of cancer, shifting lifestyles, and escalated investments in healthcare facilities. Highlights in the forecast period encompass a commitment to deliver telehealth services, forging partnerships and collaborations, forming personalized service plans, technological progress, and business mergers and acquisitions.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3369

What Are the Different Community Oncology Services Market Segments?
The community oncology services market covered in this report is segmented -

1) By Type: Small Community Oncology Clinics, Medium Community Oncology Clinics, Large Community Oncology Clinics
2) By Cancer Type: Breast Cancer, Lung Cancer, Kidney Cancer, Ovarian Cancer, Prostate Cancer, Skin Cancer, Pancreatic Cancer, Blood Cancer, Colorectal Cancer, Other Cancer Types
3) By Therapy Type: Medical Oncology, Radiation Oncology, Surgical Oncology, Other Therapies

Subsegments:
1) By Small Community Oncology Clinics: Independent Oncology Practices, Single-Physician Oncology Offices, Community-Based Cancer Screening and Prevention Services
2) By Medium Community Oncology Clinics: Multi-Physician Oncology Practices, Integrated Community Cancer Centers, Outpatient Treatment Facilities, Community-Based Clinical Trials
3) By Large Community Oncology Clinics: Comprehensive Cancer Centers, Academic-affiliated Community Oncology Practices, Multi-disciplinary Treatment Centers, Specialized Oncology Services

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3369&type=smp

What Are the Primary Drivers Shaping the Community Oncology Services Market?
Anticipations are high for increased demand in the community oncology service market, due to the affordability of care in community oncology centers. Community oncology centers are believed to offer more cost-effective cancer care services compared to hospitals. A report from the Community Oncology Alliance indicates that the per patient per month cost of cancer care for various tumors in community-based clinics (CCs) hovered around $12,000, while in hospital-based oncology clinics (HCs), it stood at about $20,000. Furthermore, the monthly cost per patient for chemotherapy treatment in a community setting was approximately $5,000, contrasted with nearly $8,500 in hospital-based clinics. Therefore, the affordability of community oncology settings, or community oncology centers, is predicted to be a key driver fueling the growth of the community oncology services market in the predicted years.

Which Companies Are Leading in the Community Oncology Services Market?
Major companies operating in the community oncology services market include The US Oncology Network, OneOncology, Florida Cancer Specialists & Research Institute (FCS), The Oncology Institute, Community Care Physicians, P.C. (CCP), GenesisCare, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Nanjing Legend Pharmaceutical & Chemical Co., Ltd, Zai Labare, Taxane HealthCare Pvt Ltd, Getwell Oncology, Novartis Oncology, Celgene, Johnson & Johnson, Janssen Pharma, Pharmacyclics, Healthkind Labs Pvt Ltd, Arlak Biotech, SwisscheM Healthcare Pvt Ltd, Apikos Pharma, Kolaz Biotech, Quironsalud Proton Therapy Centre, The London Clinic England, Institut Gustave Roussy, Netherlands Cancer Institute, European Medical Center, Yauza Medical Center, Celon Pharma, Nebraska Cancer Specialists, Tufts Medical Center, Doctors Medical Center, Oncology Specialists SC, Baptist Cancer Center, Mayo Clinic, Cleveland Clinic, Fred Hutchinson Cancer Research Center, The University of Texas Southwestern Medical Center, Abramson Cancer Center, McKesson Corporation, TUTEUR Argentina, Takeda Pharmaceutical Company Limited, Pierre Fabre Group, Celnova Pharma, King Hussein Cancer Center (KHCC), Princess Noorah Oncology Center (PNOC), King Abdulaziz Medical City, King Faisal Specialist Hospital and Research Centre, King Fahd Specialist Hospital, Prince Sultan Medical Military City, King Saud Medical City, King Abdullah Medical City, Tawam Hospital, Icon Oncology, Eurolab Science Laboratuvar, Yemaachi Biotechnology, Regal Pharmaceuticals Limited, Ocean Road Cancer Institute

What Are the Major Trends Shaping the Community Oncology Services Market?
Leading firms in the community oncology services market are engaging in acquisitions and research partnerships in a bid to enrich their service offering, a trend that has gained considerable traction in recent years. For example, in April 2023, TPG, a private equity firm from the US, and the AmerisourceBergen Corporation, a US-based wholesale enterprise, purchased OneOncology for a sum of 2.1 billion. This deal allows both TPG and AmerisourceBergen to bolster their specialty practice network presence and amplify their oncology solution offerings. OneOncology is a US company dedicated to revolutionizing patient experiences and resolving the challenges community oncology faces, simultaneously staying ahead in cancer prevention and treatment.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/community-oncology-services-global-market-report

What Are the Top Revenue-Generating Geographies in the Community Oncology Services Market?
North America was the largest region in the community oncology services market in 2024. Western Europe was the second largest region in the global oncology services market. The regions covered in the community oncology services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Community Oncology Services Market?
2. What is the CAGR expected in the Community Oncology Services Market?
3. What Are the Key Innovations Transforming the Community Oncology Services Industry?
4. Which Region Is Leading the Community Oncology Services Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.